Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Changes in Beneficial Ownership · 4

Immatics N.V.

IMTXNASDAQEQUITYCurrent

Changes in Beneficial Ownership

Filed Aug 27, 2026Accepted Aug 27, 2026, 4:00 PM EDTFiling CIK 1809196Accession 0001193125-26-371237
Share

Structured filing — 4

ownership.xml

Open full document ↗

Filing details

Report period
2026-08-26
Issuer
Immatics N.V.
Issuer CIK
0001809196
Trading symbol
IMTX

Reporting owner 1

Name
PERCEPTIVE ADVISORS LLC
Reporting owner CIK
0001224962
Relationship
Director
Address
51 ASTOR PLACE, 10TH FLOOR, NEW YORK, NY, 10003

Reporting owner 2

Name
EDELMAN JOSEPH
Reporting owner CIK
0001164426
Relationship
Director
Address
51 ASTOR PLACE, 10TH FLOOR, NEW YORK, NY, 10003

Reporting owner 3

Name
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
Reporting owner CIK
0001249675
Relationship
Director
Address
51 ASTOR PLACE, 10TH FLOOR, NEW YORK, NY, 10003

Non-derivative transactions

Non-derivative transactions · 1 reported row
SecurityTransaction dateCodeAmountA / DPrice (USD)Owned afterOwnershipNature of ownership
Ordinary Shares2026-08-26P · Form 4863,060A8.6911,246,516ISee Footnote[F1]
Table key
P · Form 4
Purchase on the market or privately
A
Acquired
I
Indirect

Footnotes

F1
The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager to the Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.↩ 1

Signature 1

Signed
/s/ Joseph Edelman - for Perceptive Advisors LLC, By: Joseph Edelman
Date
2026-08-27

Signature 2

Signed
/s/ Joseph Edelman - for Perceptive Life Sciences Master Fund Ltd., By: Perceptive Advisors LLC, its investment manager, By: Joseph Edelman, its managing member
Date
2026-08-27

Signature 3

Signed
/s/ Joseph Edelman
Date
2026-08-27

Company context

Immatics is committed to making a meaningful impact on the lives of patients with cancer. We are the global leader in precision targeting of PRAME, a target expressed in more than 50 cancers. Our cutting-edge science and robust clinical pipeline form the broadest PRAME franchise with the most PRAME indications and modalities, spanning TCR T-cell therapies and TCR bispecifics. Immatics intends to use its website www.immatics.com as a means of disclosing material non-public information. For regular updates, you can also follow us on LinkedIn and Instagram.

Current securities

Historical securities (1)

Recent company filings

  1. SCHEDULE 13G/A - filed by BAKER BROS. ADVISORS LP regarding Immatics N.V.Nov 16, 2026
  2. SCHEDULE 13G/A - filed by MONTANOVA CAPITAL, LLC regarding Immatics N.V.Nov 13, 2026
  3. 6-K filingNov 10, 2026
  4. 6-K filingOct 26, 2026
  5. 6-K filingOct 23, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.